Gain Therapeutics, Inc. is delighted to announce the appointment of Jonas Hannestad as the new Chief Medical Officer. With over two decades of leadership in clinical development, Jonas brings a wealth of expertise to Gain at a pivotal moment in their mission to combat Parkinson’s disease and related neurodegenerative conditions.
Jonas has a rich background in neurological disease research, having served as Chief Medical Officer at Tranquis Therapeutics, Inc., where he led clinical developments including the progression of novel compounds through Phase 1 trials. Prior to his tenure at Tranquis, he significantly contributed to clinical strategies at Capacity Bio, focusing on therapies for neurodegenerative and neuromuscular disorders.
In addition to his roles at major biotech firms, Jonas has also been an influential clinical development advisor at companies like Reservoir Neuroscience and Proximity Therapeutics. His extensive experience includes strategic roles in leading and advising on clinical operations, drug safety, and regulatory affairs across various companies within the healthcare sector.
Get Your Organization Happy Place To Work (HPTW) Certified : Why Workplace Happiness Matters Now More Than Ever
HAPPY PLACE TO WORK INSTITUTE (www.happyplacetowork.org)
Jonas holds a Bachelor’s degree in medical sciences and a Master’s degree in neuropharmacology, underscoring his deep scientific foundation which complements his clinical achievements. His appointment is expected to accelerate Gain Therapeutics’ clinical programs, particularly enhancing their innovative approaches to treating Parkinson’s disease.
